Quadrature Capital Ltd raised its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 60.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 19,666 shares of the company's stock after purchasing an additional 7,422 shares during the quarter. Quadrature Capital Ltd's holdings in Cardinal Health were worth $2,173,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently made changes to their positions in CAH. Eastern Bank acquired a new stake in shares of Cardinal Health in the third quarter valued at approximately $25,000. Cultivar Capital Inc. acquired a new position in Cardinal Health in the second quarter worth approximately $27,000. Frazier Financial Advisors LLC grew its position in Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock worth $28,000 after buying an additional 104 shares during the last quarter. Ashton Thomas Private Wealth LLC acquired a new position in Cardinal Health in the second quarter worth approximately $29,000. Finally, Hara Capital LLC acquired a new position in Cardinal Health in the third quarter worth approximately $31,000. Institutional investors and hedge funds own 87.17% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms recently commented on CAH. Mizuho began coverage on shares of Cardinal Health in a research note on Wednesday. They issued an "outperform" rating and a $139.00 price objective for the company. Morgan Stanley raised their price objective on shares of Cardinal Health from $119.00 to $127.00 and gave the stock an "overweight" rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Cardinal Health from $119.00 to $124.00 and gave the company a "hold" rating in a research note on Monday, November 4th. Argus lifted their target price on shares of Cardinal Health from $115.00 to $125.00 and gave the company a "buy" rating in a research note on Wednesday, September 11th. Finally, UBS Group lifted their target price on shares of Cardinal Health from $134.00 to $139.00 and gave the company a "buy" rating in a research note on Monday, November 4th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, Cardinal Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $124.58.
Read Our Latest Stock Report on CAH
Cardinal Health Price Performance
Shares of Cardinal Health stock traded down $0.08 during trading on Friday, hitting $122.76. 1,583,924 shares of the company's stock traded hands, compared to its average volume of 2,228,541. The firm's fifty day moving average price is $116.29 and its 200 day moving average price is $107.56. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $126.23. The company has a market cap of $29.71 billion, a PE ratio of 23.88, a PEG ratio of 1.57 and a beta of 0.61.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The firm had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The company's revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.73 earnings per share. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 7.82 earnings per share for the current year.
Cardinal Health Cuts Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a $0.5056 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.65%. Cardinal Health's dividend payout ratio (DPR) is presently 39.30%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.